Sorry, you need to enable JavaScript to visit this website.

Looking to enter the Japanese market?

Exclusively for our contract manufacturing partners, learn about our

Japan gateway services

Our Capabilities:
Sterile Injectables

Compounds

  • Biologics
  • Small molecules
  • Inactivated vaccines
  • Controlled substances
  • Liquid cytotoxics
  • High potency

Processes

  • Aseptic processing
  • Terminal sterilization

Container closure systems

  • Vials
  • Prefilled syringes
  • Cartridges
  • Ampoules
  • Flexible containers
  • Proprietary systems for hazardous drugs
  • Delivery systems designed for hospital and ambulatory drug administration

For fill volumes and other details, see container closure systems.

Capabilities by site

Kalamazoo, MI, USA Rocky Mount, NC, USA Melbourne, Australia Zagreb, Croatia
cGMP inspectionsFDA,
EMA,
ANVISA,
China FDA,
Health Canada,
MHRA,
PMDA,
TGA
FDA,
EMA,
ANVISA,
Health Canada,
MHRA,
PMDA,
TGA
FDA,
EMA,
ANVISA,
GCC,
Korean FDA,
PMDA,
Taiwanese MOH,
TGA
EMA,
GCC-DR,
TGA,
TMMDA,
FDA (for labeling and secondary packaging operations)